Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Spiegelman Daniel K
Relationship:   Director
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   5    
Direct Shares   155,668    

Indirect Shares

   6,673      
Direct Value   $5,197,837    

Indirect Value

   $0      
Total Shares   162,341      
Total Value   $5,197,837      


CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $971,427 CV Therapeutics Inc $0 Biomarin Pharmaceutical Inc $4,226,410 Myriad Genetics Inc $971,427
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    0   
    0    

     Stock price went up :
    0   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
     0.0%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            CV Therapeutics Inc CVTX SVP, CFO 2009-04-09 67,489 2009-04-09 6,673    Premium*  
            Cascadian Therapeutics, Inc CASC Director 2018-03-09 0 2009-12-04 0    Premium*  
            Biomarin Pharmaceutical Inc BMRN EVP, Chief Financial O... 2019-04-30 47,686 2012-05-29 0    Premium*  
            Relypsa Inc RLYP Director 2016-09-01 0 2015-06-04 0    Premium*  
            Myriad Genetics Inc MYGN Director 2023-06-02 40,493 2020-05-27 0    Premium*  
* Premium Members only  

Records found :    180         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 6 of 8
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-12-02 4 OE $39.06 $351,540 D/D 9,000 46,950 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-12-02 4 AS $70.14 $631,273 D/D (9,000) 37,950 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2017-06-24 4 OE $0.00 $0 D/D 9,058 21,490 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-15 4 A $0.00 $0 D/D 9,370 64,681 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-03-25 4 B $1.63 $16,271 D/D 10,000 30,644 2.39 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2015-03-26 4 B $1.59 $15,856 D/D 10,000 40,644 2.39 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-06-22 4 AS $99.00 $990,005 D/D (10,000) 51,070 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-03-03 4 A $0.00 $0 D/D 10,500 79,278 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-04-23 4 AS $82.15 $908,497 D/D (11,059) 62,543 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-03-22 4 A $0.00 $0 D/D 12,200 26,671 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-03-01 4 A $0.00 $0 D/D 12,205 63,450 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2017-02-24 4 A $0.00 $0 D/D 12,247 30,347 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-03-15 4 A $0.00 $0 D/D 12,480 77,185 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2009-02-25 4 OE $15.58 $194,734 D/D 12,499 29,075 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2007-11-09 4 A $10.12 $126,500 D/D 12,500 18,488 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-02-26 4 A $0.00 $0 D/D 12,529 70,129 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2018-02-26 4/A A $0.00 $0 D/D 12,615 70,215 0 -
CVTX CV Therapeutics Inc SVP, CFO   •       –      –    2007-01-03 4 OE $0.00 $0 D/D 12,732 11,884 0 -
CASC Cascadian Therapeutics, I... Director   –       •      –    2013-02-20 4 S $1.96 $25,054 D/D (12,780) 24,047 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2021-06-03 4 A $0.00 $0 D/D 12,848 26,268 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2013-05-15 4 A $0.00 $0 D/D 13,200 46,200 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2019-04-01 4 AS $89.00 $1,199,097 D/D (13,473) 47,510 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2014-06-04 4 A $0.00 $0 D/D 13,800 73,134 0 -
MYGN Myriad Genetics Inc Director   –       •      –    2023-06-01 4 A $0.00 $0 D/D 15,151 49,131 0 -
BMRN Biomarin Pharmaceutical I... EVP, Chief Financial Officer   •       –      –    2015-03-02 4 S $107.00 $1,658,500 D/D (15,500) 68,676 0 -
  180  Records found
  1   2   3   4   5   6  7   8      
  Page 6 of 8  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us